A detailed history of Clearstead Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 124,293 shares of MRK stock, worth $12.4 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
124,293
Previous 119,087 4.37%
Holding current value
$12.4 Million
Previous $14.7 Million 4.26%
% of portfolio
0.22%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $578,646 - $671,417
5,206 Added 4.37%
124,293 $14.1 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $5.73 Million - $6.16 Million
46,305 Added 63.62%
119,087 $14.7 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $34,311 - $39,980
-303 Reduced 0.41%
72,782 $9.6 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $160,087 - $174,213
1,598 Added 2.24%
73,085 $7.97 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $3.08 Million - $3.42 Million
-29,894 Reduced 29.49%
71,487 $7.36 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $3.19 Million - $3.54 Million
30,997 Added 44.04%
101,381 $10.4 Million
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $256,319 - $279,376
2,360 Added 3.47%
70,384 $8.12 Million
Q1 2023

May 09, 2023

BUY
$102.94 - $114.86 $49,720 - $55,477
483 Added 0.72%
68,024 $7.24 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $72,050 - $92,378
-824 Reduced 1.21%
67,541 $7.49 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $2.08 Million - $2.33 Million
-24,574 Reduced 26.44%
68,365 $5.89 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $18,785 - $21,294
-225 Reduced 0.24%
92,939 $8.47 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $243,171 - $272,579
3,308 Added 3.68%
93,164 $7.64 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $178,459 - $223,543
2,469 Added 2.83%
89,856 $6.89 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $48,168 - $52,973
672 Added 0.77%
87,387 $6.56 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $62,013 - $68,593
882 Added 1.03%
86,715 $6.74 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $1.15 Million - $1.36 Million
16,727 Added 24.2%
85,833 $6.62 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $1.38 Million - $1.53 Million
19,182 Added 38.42%
69,106 $5.65 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $181,998 - $206,296
-2,487 Reduced 4.75%
49,924 $4.14 Million
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $59,504 - $67,709
845 Added 1.64%
52,411 $4.05 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $207,187 - $287,171
-3,270 Reduced 5.96%
51,566 $3.97 Million
Q4 2019

Feb 11, 2020

BUY
$77.58 - $87.54 $67,029 - $75,634
864 Added 1.6%
54,836 $4.99 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $40,854 - $44,533
-537 Reduced 0.99%
53,972 $4.54 Million
Q2 2019

Aug 08, 2019

BUY
$69.84 - $81.59 $69,909 - $81,671
1,001 Added 1.87%
54,509 $4.57 Million
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $184,456 - $210,383
2,651 Added 5.21%
53,508 $4.45 Million
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $118,671 - $137,716
1,819 Added 3.71%
50,857 $3.89 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $68,074 - $80,051
1,180 Added 2.47%
49,038 $3.48 Million
Q2 2018

Aug 07, 2018

BUY
$50.83 - $59.72 $70,094 - $82,353
1,379 Added 2.97%
47,858 $2.91 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $236,709 - $275,123
4,645 Added 11.1%
46,479 $2.53 Million
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $178,863 - $213,582
-3,465 Reduced 7.65%
41,834 $2.36 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $2.66 Million - $2.86 Million
45,299
45,299 $2.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.